NARCOLEPSY WITH CATAPLEXY

Clinical trials for NARCOLEPSY WITH CATAPLEXY explained in plain language.

Never miss a new study

Get alerted when new NARCOLEPSY WITH CATAPLEXY trials appear

Sign up with your email to follow new studies for NARCOLEPSY WITH CATAPLEXY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New drug trial aims to tame sudden sleep attacks

Disease control Recruiting now

This study is testing if an investigational drug called TAK-861 can effectively control the symptoms of narcolepsy type 1, a sleep disorder that causes severe daytime sleepiness and sudden muscle weakness (cataplexy). About 88 participants worldwide will take the drug for several…

Matched conditions: NARCOLEPSY WITH CATAPLEXY

Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

NARCOLEPSY WITH CATAPLEXY

Get alerted when new NARCOLEPSY WITH CATAPLEXY trials appear

New drug trial aims to tame sudden sleep attacks